ZEISS continues to strengthen its leadership team
Introduction in the US of the VisuMax® SMILE procedure
Andrew Ihan Chang will lead the worldwide sales organization
Carl Zeiss Meditec AG consolidates its ophthalmology activities
Recent clinical studies show excellent refractive outcomes by surgeons using ZEISS Cataract Suite markerless
12/8/2016 – 12/10/2016
Thailand / Bangkok
01/30/2017 – 02/02/2017
Dubai / UAE
Digitization is an excellent opportunity for the healthcare sector, allowing for instance for software-supported visualization techniques for life-saving surgeries. Explore a fascinating expedition through our digital solutions! Take part in the game: Answer some questions and slip into the role of your dentist and test how well you can handle a needle and drill.
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organisation. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.
Carl Zeiss Meditec AG Website
ZEISS is one of the world’s leading suppliers of medical devices in the field of medical technology. It supplies innovative technologies and application-oriented solutions for ophthalmology and microsurgery designed to help doctors improve the quality of life of their patients.
ZEISS provides complete packages of solutions for diagnosis and devices for optical coherence tomography (OCT), perimetry, optical biometry and slit lamps. For the treatment of eye diseases ZEISS also offers not only ophthalmologic surgical microscopes, but also implants (intraocular lenses | IOLs) and consumables like ophthalmic viscosurgical devices (OVDs).
Within the field of microsurgery ZEISS creates innovative visualization solutions, especially surgical microscopes for minimally invasive surgeries. The medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy.
Most of ZEISS’s medical technology activities are combined into Carl Zeiss Meditec AG, which is listed on TecDax of the German stock exchange. For more information, please click here.